You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ipilimumab

Showing 26 - 50 of 387
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Ipilimumab
  • +6 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Nasopharyngeal Carcinoma Trial in Singapore (Ipilimumab, Nivolumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jul 20, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Ipilimumab
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

Recruiting
  • Breast Cancer
  • Ipilimumab
  • +3 more
  • Los Angeles, California
  • +2 more
Sep 27, 2022

NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Thoracic Radiotherapy
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 30, 2022

Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

Recruiting
  • Mesothelioma
  • LMB-100
  • ipilimumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
Has Results
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Ocular Melanoma
  • San Francisco, California
  • +5 more
Aug 31, 2022

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting
  • Oncology
  • Infusion Reaction
  • (no location specified)
Sep 8, 2023

Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

Recruiting
  • Neuroblastoma
  • Pediatric Solid Tumor
  • Tissue collection
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 17, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Ipilimumab
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Renal Cell Carcinoma Trial in Switzerland (nivolumab, ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Aarau, Switzerland
  • +13 more
Oct 17, 2022

Advanced Melanoma Trial in United States (FLX475, Ipilimumab)

Recruiting
  • Advanced Melanoma
  • Los Angeles, California
  • +3 more
Jun 10, 2022

Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

Recruiting
  • Lung Cancer Metastatic
  • Durham, North Carolina
    Duke Univ. Medical Center
May 16, 2022

Melanoma Trial in United States (CAVATAK, Ipilimumab)

Completed
  • Melanoma
  • CAVATAK
  • Ipilimumab
  • Duarte, California
  • +10 more
Jan 12, 2023

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Recruiting
  • Advanced Solid Tumors
  • Boston, Massachusetts
  • +5 more
Jan 10, 2023

Non Small Cell Lung Cancer Trial in Toronto (diagnostic test, drug, combination product)

Recruiting
  • Non Small Cell Lung Cancer
  • cfDNA blood test
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 9, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

Completed
  • Metastatic Hormone-Sensitive Prostate Cancer
  • PROSTVAC-V
  • +9 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 3, 2022